Superficial X-ray viable for basal, squamous cell carcinoma

August 6, 2012
Superficial X-ray viable for basal, squamous cell carcinoma
Superficial X-ray therapy remains a viable treatment for primary basal cell carcinoma and squamous cell carcinoma in select patients, according to a study published online July 23 in the Journal of the American Academy of Dermatology.

(HealthDay) -- Superficial X-ray therapy remains a viable treatment for primary basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in select patients, according to a study published online July 23 in the Journal of the American Academy of Dermatology.

To examine the efficacy and viability of superficial X-ray therapy in the treatment of BCC and SCC, Armand B. Cognetta, M.D., from Dermatology Associates of Tallahassee in Florida, and colleagues conducted a retrospective analysis of 1,715 histologically confirmed primary cutaneous BCC and SCC among outpatients seen between 2000 and 2010. All tumors were treated with superficial X-ray therapy.

Of the tumors reviewed, the researchers found that 712 were histologically proven BCC (631 nodular and 81 superficial), 994 were SCC, and nine displayed features of both BCC and SCC. At two and five years, the cumulative recurrence rates were 1.9 and 5.0 percent, respectively, for all tumors; 2.0 and 4.2 percent, respectively, for all BCC; and 1.8 and 5.8 percent, respectively, for all SCC. There was a significantly increased likelihood of recurrence for tumors on male patients and tumors with a diameter greater than 2 cm.

"Superficial X-ray therapy remains a viable nonsurgical option for the treatment of primary BCC and SCC in patients where surgical intervention is declined, unadvisable, or potentially associated with significant cosmetic or ," the authors write.

One author disclosed financial ties to Sensus Health Care.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study finds psoriasis treatment increases skin cancer risk

March 29, 2012

(HealthDay) -- The long-term risk of squamous cell carcinoma (SCC) is significantly increased for patients with severe psoriasis who receive more than 350 psoralen and ultraviolet A (PUVA) treatments compared with those who ...

Basal cell carcinoma on ear significantly more aggressive

April 18, 2012

(HealthDay) -- Basal cell carcinoma (BCC) on the ear is significantly more likely to be aggressive, and occurs more frequently in men, according to a study published in the May issue of the Journal of the American Academy ...

Recommended for you

Strange circular DNA may offer new way to detect cancers

July 30, 2015

Strange rings of DNA that exist outside chromosomes are distinct to the cell types that mistakenly produced them, researchers have discovered. The finding raises the tantalizing possibility that the rings could be used as ...

New treatment options for a fatal leukemia

July 27, 2015

In industrialized countries like in Europe, acute lymphoblastic leukemia is the most common form of cancer in children. An international research consortium lead by pediatric oncologists from the Universities of Zurich and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.